Asymmetric Dimethylarginin (ADMA) as a Marker of Endothelial Dysfunction in Primary Aldosteronism

BACKGROUND: Recent studies have revealed a higher rate of cardiovascular complications in primary aldosteronism (PA) compared to patients with essential hypertension (EH). Asymmetric dimethylarginine (ADMA) is a marker of endothelial dysfunction that could contribute to increased cardiovascular risk...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Int J Endocrinol Metab
Auteurs principaux: Matrozova, Joanna, Vasilev, Vladimir, Vandeva, Silvia, Elenkova, Atanaska, Kirilov, Georgi, Zaharieva, Sabina
Format: Artigo
Langue:Inglês
Publié: Kowsar 2016
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5237362/
https://ncbi.nlm.nih.gov/pubmed/28123434
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5812/ijem.30324
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires